Common Vector-Borne Diseases: Real-World Examples
Vector-borne diseases, transmitted from infected animals to humans through vectors like mosquitoes, ticks, or fleas, pose significant health threats worldwide. Understanding these ailments is crucial for prevention and control, as highlighted by the World Health Organization (WHO). Let's delve into some common examples of vector-borne diseases.
Vector-borne diseases are diverse, affecting various systems in the body, from the nervous system to the blood. They sulfide in different climates and geographies, with tropical and subtropical regions often reporting the highest incidence.
Arboviral Diseases
Arboviral diseases, transmitted by arthropods (such as mosquitoes and ticks), include some of the most common vector-borne illnesses. They primarily affect the circulatory system and the nervous system. Let's explore two notable examples.
The first arboviral disease worth mentioning is dengue fever, caused by the dengue virus and transmitted by Aedes mosquitoes. According to the WHO, dengue affects up to 400 million people globally each year, with 96 million cases reported in 2010 alone. Symptoms of dengue range from mild fever to severe hemorrahagia, which can be life-threatening.
Dengue Fever
Dengue fever is a critical public health concern, especially in urban areas, due to its aggressive transmission in densely populated, poorly-managed cities. The population growth and unplanned urbanization have further fuelled the dengue epidemic in many countries.
Another significant arboviral disease is Japanese encephalitis (JE), primarily found in rural areas of South Asia and South-East Asia. Caused by the Japanese encephalitis virus, it's transmitted by Culex mosquitoes, leading to inflammation of the brain. JE affects around 68,000 people annually, with a case-fatality rate of approximately 20-30%.
Japanese Encephalitis
JE is a major cause of viral encephalitis in these regions, with the highest disease burden in children, particularly in rural areas where vaccination coverage is often inadequate. The scarcity of effective antiviral drugs for JE underscores the importance of vaccines and preventive methods.
Plasmodial Diseases
The plasmodial diseases, caused by single-celled parasites of the genus Plasmodium, are primarily spread through the bites of infected female Anopheles mosquitoes. Two primary diseases stand out in this group: Malaria and Filariasis.
Malaria is a massive global health challenge, affecting more than 200 million people each year, with children under five years and pregnant women being the most vulnerable. The disease is widespread across Africa, the Americas, South-East Asia, and the Western Pacific. Its treatment is complicated due to antimalarial drug resistance.
Malaria
Malaria symptoms include fever, fatigue, and flu-like illness, which can rapidly progress to severe complications and death in untreated cases. In 2016, there were an estimated 445,000 malaria deaths worldwide, with 91% of them occurring in the African Region. The global malaria control programs focus on vector control, diagnosis, treatment, and prevention, with various organizations working to eliminate the disease.
The second notable plasmodial disease is lymphatic filariasis, often referred to as elephantiasis due to the grotesque swelling of limbs that it can cause. It's the second leading cause of permanent disability worldwide. Transmission occurs through Culex, Anopheles, and Aedes mosquitoes, with the disease primarily affecting the lymphatic system.
Lymphatic Filariasis
Lymphatic filariasis is typically asymptomatic, but when symptoms do appear, they can include... fatigue, itching, and temporarily enlarged local lymph nodes. In its most advanced stages, the parasitic obstruction of lymphatic vessels leads to serious abnormalities known as elephantiasis, which affects the skin and, in some cases, internal organs. In 2018, approximately 696 million people in 54 countries were at risk of infection, with over 56 million people infected. However, significant progress has been made in lymphatic filariasis control and elimination, particularly in the Americas, the Pacific, and parts of Southeast Asia.
The complex nature of vector-borne diseases demands integrated, multi-level responses, involving health services, communities, and policymakers. Enhanced research, surveillance, and control measures are all equally vital in tackling this diverse group of diseases. It's high time we bolster our collective efforts to minimize the global burden of vector-borne diseases.